| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Valerio Ricci, Enrico Cristofori, Erica Passarello, Andrea Paggi, Alex Cavallo, Franca Ceci, Giovanni Martinotti, Domenico De Berardis, Giuseppe Main. CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE. Psychiatria Danubina. vol 35. issue 3. 2023-11-02. PMID:37917836. |
proof of correlation between psychotic spectrum disorders and suicide are found in literature, as well as between cannabis use disorder (cud) and suicide and between cud and schizophrenia. |
2023-11-02 |
2023-11-08 |
human |
| Leanne Trick, Kevin Butler, Zoe Bourgault, Julianne Vandervoort, Bernard Le Fol. Implementation and Preliminary Evaluation of a 12-Week Cognitive Behavioural and Motivational Enhancement Group Therapy for Cannabis Use Disorder. Substance abuse : research and treatment. vol 17. 2023-10-31. PMID:37904747. |
the purpose of this paper is to provide a preliminary evaluation of treatment outcomes, retention and client satisfaction following a 12-week combined cognitive behavioural therapy (cbt) and motivational enhancement therapy (met) group treatment for cannabis use disorder (cud) delivered in an outpatient setting. |
2023-10-31 |
2023-11-08 |
Not clear |
| Nadia Boachie, Erin Gaudette, Richard P Bazinet, Lin Lin, Rachel F Tyndale, Esmaeil Mansouri, Marilyn A Huestis, Junchao Tong, Bernard Le Foll, Stephen J Kish, Tony P George, Isabelle Boilea. Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder-Preliminary Findings. Brain sciences. vol 13. issue 10. 2023-10-30. PMID:37891745. |
although chronic cannabis use is associated with endocannabinoid system changes, the status of circulating endocannabinoids and related naes in people with cannabis use disorder (cud) is uncertain. |
2023-10-30 |
2023-11-08 |
Not clear |
| Zach J Leinen, Rahul Mohan, Lakmini S Premadasa, Arpan Acharya, Mahesh Mohan, Siddappa N Byraredd. Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines. vol 11. issue 10. 2023-10-30. PMID:37893004. |
the long-term recreational use of cannabis can develop into cannabis use disorder (cud), and therefore, understanding the factors contributing to the development and maintenance of cannabis addiction, including genetic predisposition, neurobiological mechanisms, and environmental influences, will be timely. |
2023-10-30 |
2023-11-08 |
human |
| Zach J Leinen, Rahul Mohan, Lakmini S Premadasa, Arpan Acharya, Mahesh Mohan, Siddappa N Byraredd. Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines. vol 11. issue 10. 2023-10-30. PMID:37893004. |
shedding light on the adverse impacts of cud underscores the importance of early intervention, effective treatment approaches, and public health initiatives to address this complex issue in an evolving landscape of cannabis policies and perceptions. |
2023-10-30 |
2023-11-08 |
human |
| Palani S Mohanraj, Arani Das, Aniruddha Sen, Manoj Prithvira. Brain-Derived Neurotrophic Factor Levels in Cannabis Use Disorders - A Systematic Review and Meta-Analysis. Cureus. vol 15. issue 9. 2023-10-30. PMID:37900486. |
the prevalence of cannabis use disorders has become a noteworthy global public health issue. understanding the neurobiological factors associated with cannabis use disorder (cud) is crucial for creating effective interventions. |
2023-10-30 |
2023-11-08 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse D Hinckle. Treatment of Adolescent Cannabis Use Disorders. The Psychiatric clinics of North America. vol 46. issue 4. 2023-10-25. PMID:37879838. |
this review summarizes treatments for cannabis use disorder (cud) in adolescents. |
2023-10-25 |
2023-11-08 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse D Hinckle. Treatment of Adolescent Cannabis Use Disorders. The Psychiatric clinics of North America. vol 46. issue 4. 2023-10-25. PMID:37879838. |
the best supported cud treatments are cognitive behavioral psychotherapies, including family-based models that facilitate environmental changes and youth-focused models that incorporate skills training, motivational interviewing, and contingency management to promote reductions in cannabis use. |
2023-10-25 |
2023-11-08 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse D Hinckle. Treatment of Adolescent Cannabis Use Disorders. The Psychiatric clinics of North America. vol 46. issue 4. 2023-10-25. PMID:37879838. |
further research is needed on the efficacy and implementation of existing treatments given the changes in cannabis use trends over time and on emerging technologies that may expand access to evidence-based cud treatments. |
2023-10-25 |
2023-11-08 |
Not clear |
| Rupak Desai, Brian Brereton, Harika Varma Chintapalli Patta, Prerna Bansal, Akhil Jain, Ankit Vya. Prevalence and Impact of Cannabis Use Disorder on Acute Ischemic Stroke and Subsequent mortality in Elderly Peripheral Vascular Disease Patients: A Population-based Analysis in the USA (2016 - 2019). Current problems in cardiology. 2023-10-23. PMID:37871709. |
given current evidence linking peripheral atherosclerotic disease, also known as cannabis arteritis, and acute ischemic stroke (ais) in individuals with cannabis use disorder (cud), we investigated the frequency and implications of cud in relation to ais risk and outcomes among elderly patients with peripheral vascular disease (pvd). |
2023-10-23 |
2023-11-08 |
Not clear |
| Dustin C Lee, Nicolas J Schlienz, Evan S Herrman, Erin L Martin, Jeannie Leoutsakos, Alan J Budney, Michael T Smith, D Andrew Tompkins, Aiden J Hampson, Ryan Vandre. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. Journal of substance use and addiction treatment. 2023-10-06. PMID:37802317. |
sleep disturbance is commonly reported among individuals meeting criteria for cannabis use disorder (cud), and cannabis users frequently report sleep disturbance as a contributor to failed quit attempts. |
2023-10-06 |
2023-10-15 |
Not clear |
| Katarina Guttmannova, Charles B Fleming, Isaac C Rhew, Miranda L M Delawalla, Anne M Fairlie, Mary E Larimer, Jason R Kilme. Changes in cannabis use from 2014-2019 among young adults in Washington State. American journal of preventive medicine. 2023-10-04. PMID:37793557. |
with a focus on wa young adults, this study conducted in 2022/2023 examined changes in (1) cannabis use by sex and age, (2) preferred mode of use, and (3) cannabis use disorder (cud) symptoms. |
2023-10-04 |
2023-10-07 |
Not clear |
| Anees Bahji, Josh Hathaway, Denise Adams, David Crockford, E Jennifer Edelman, Michael D Stein, Scott B Patte. Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada. Addiction (Abingdon, England). 2023-09-28. PMID:37766508. |
to measure the association between cannabis use disorder (cud) and adverse cardiovascular disease (cvd) outcomes. |
2023-09-28 |
2023-10-07 |
Not clear |
| Erin L Martin, Nathaniel L Baker, Cristina Sempio, Uwe Christians, Jost Klawitter, Aimee L McRae-Clar. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction biology. vol 28. issue 10. 2023-09-27. PMID:37753564. |
cannabis use disorder (cud) presents differently in men and women, particularly in symptoms of cannabis withdrawal. |
2023-09-27 |
2023-10-07 |
human |
| Erin L Martin, Nathaniel L Baker, Cristina Sempio, Uwe Christians, Jost Klawitter, Aimee L McRae-Clar. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction biology. vol 28. issue 10. 2023-09-27. PMID:37753564. |
the present pilot study sought to prospectively assess sex differences in cannabis withdrawal in a small sample of adults with moderate-to-severe cud and to determine if withdrawal was associated with peripheral ecb and ecb congener tone. |
2023-09-27 |
2023-10-07 |
human |
| Erin L Martin, Nathaniel L Baker, Cristina Sempio, Uwe Christians, Jost Klawitter, Aimee L McRae-Clar. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction biology. vol 28. issue 10. 2023-09-27. PMID:37753564. |
pharmacotherapeutic development for cud should consider evident sex differences in ecb and ecb congener tone during abstinence and their associations with cannabis withdrawal, as ecb-based interventions may produce differential effects by sex. |
2023-09-27 |
2023-10-07 |
human |
| Mohammad Darharaj, Mohsen Roshanpajouh, Mahdi Amini, Lydia A Shrier, Mojtaba Habibi Asgaraba. The effectiveness of mobile-based ecological momentary motivational enhancement therapy in reducing craving and severity of cannabis use disorder: Study protocol for a randomized controlled trial. Internet interventions. vol 34. 2023-09-25. PMID:37746638. |
this study aims to investigate the effectiveness of ecological momentary motivational enhancement therapy (em-met) in reducing craving and severity of cannabis use disorder (cud) among young adults. |
2023-09-25 |
2023-10-07 |
Not clear |
| Cara A Struble, Jacob T Borodovsky, Mohammad I Habib, Ofir Livne, Claire A Walsh, Efrat Aharonovich, Deborah S Hasin, Alan J Budne. Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults. Addictive behaviors. vol 148. 2023-09-25. PMID:37748224. |
lgbt+ adults demonstrate greater cannabis-related problems (e.g., cannabis use disorder [cud]) compared to non-lgbt+ counterparts. |
2023-09-25 |
2023-10-07 |
Not clear |
| Cara A Struble, Jacob T Borodovsky, Mohammad I Habib, Ofir Livne, Claire A Walsh, Efrat Aharonovich, Deborah S Hasin, Alan J Budne. Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults. Addictive behaviors. vol 148. 2023-09-25. PMID:37748224. |
no study has explored age-related disparities in cannabis problems across the adult lifespan, nor have studies identified specific cud criteria that contribute to elevated cud among lgbt+ adults. |
2023-09-25 |
2023-10-07 |
Not clear |
| Cara A Struble, Jacob T Borodovsky, Mohammad I Habib, Ofir Livne, Claire A Walsh, Efrat Aharonovich, Deborah S Hasin, Alan J Budne. Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults. Addictive behaviors. vol 148. 2023-09-25. PMID:37748224. |
the purpose of this study was to examine associations between lgbt+ identity and age with endorsement of cud criteria in a sample of regular cannabis consumers. |
2023-09-25 |
2023-10-07 |
Not clear |